Evidence map›Paper›PMID 42889341›Full record

ArticleFrontiers in bioengineering and biotechnology2026

Proof-of-concept validation and characterisation of a DLP 3D bioprinted vascularised colorectal cancer model.

Atanas Valev, Yordan Sbirkov, David Liebl, Eva Ďurinová, Daniela Popelková, Aleš Benda, Michael Ausserlechner, Murad Redzheb, Victoria Sarafian

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Atanas Valev *Department of Medical Biology, Medical University of Plovdiv, Plovdiv, Bulgaria.
Yordan Sbirkov *Department of Medical Biology, Medical University of Plovdiv, Plovdiv, Bulgaria.
David LieblImaging Methods Core Facility at BIOCEV, Faculty of Science, Charles University, Prague-West, Czechia.
Eva ĎurinováImaging Methods Core Facility at BIOCEV, Faculty of Science, Charles University, Prague-West, Czechia.
Daniela PopelkováImaging Methods Core Facility at BIOCEV, Faculty of Science, Charles University, Prague-West, Czechia.
Aleš BendaImaging Methods Core Facility at BIOCEV, Faculty of Science, Charles University, Prague-West, Czechia.
Michael AusserlechnerDepartment of Pediatrics I and 3D Bioprinting Lab, Medical University of Innsbruck, Innsbruck, Austria.
Murad RedzhebMatriChem, Sofia, Bulgaria.
Victoria SarafianDepartment of Medical Biology, Medical University of Plovdiv, Plovdiv, Bulgaria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumor vascularisation is essential in promoting cancer growth and metastasis and represents a key target for efficient drug delivery. Nevertheless,

Indexed as

channelscolorectal cancerDLP bioprintingGelMAHCT-116HUVECvascularisation

Identifiers

PMID42889341
PMCPMC13669843

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.